MedPath

Cognitive Training with Non-invasive Brain Stimulation to Treat Binge Eating Disorder

Not Applicable
Completed
Conditions
Binge eating disorder
Mental and Behavioural Disorders
Eating disorders
Registration Number
ISRCTN35717198
Lead Sponsor
King's College London
Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31640997/ protocol (added 08/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34460140/ (added 29/03/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
66
Inclusion Criteria

1. Male and female community-dwelling adults between 18 and 70 years of age, who are overweight or obese according to WHO criteria (BMI =25 kg/m2)
2. Full-syndrome or sub-threshold DSM-5 Binge Eating Disorder (BED) clinical criteria met

Exclusion Criteria

1. Individuals with a significant/unstable medical or psychiatric disorders needing acute treatment in its own right (e.g., substance dependence), major psychiatric disorders (e.g., psychosis or acute suicidality)
2. Individuals taking antidepressant medication who have not been on a stable dose for at least 2 weeks
3. Individuals with a history of epileptic seizures, stroke, or brain injury, who have any implanted metal devices in the head, frequent or severe headaches or dizziness, or are pregnant or sexually active without using contraception (all contraindications to tDCS use are outlined in Brunoni et al. 2012)
4. Individuals with severe abnormalities in a blood test during the 30 days prior to participation
5. Individuals with allergies to any of the foods presented in the study
6. Individuals who smoke >10 cigarettes per day
7. Individuals who drink >3-4 units (men) or 2-3 units (women) of alcohol per day
8. A tDCS safety questionnaire will also be administered and if considered not safe to deliver tDCS, individuals will subsequently be excluded on this basis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath